Verition Fund Management LLC Amarin Corp Plcuk Transaction History

Verition Fund Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.24 - $5.18 $972,547 - $1.55 Million	-300,169 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.94 - $5.84 $1.18 Million - $1.75 Million	300,169 New	300,169 $1.53 Million
Q2 2020 Aug 14, 2020	SELL	$4.78 - $8.26 $53,746 - $92,875	-11,244 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$4.0 - $21.53 $3,480 - $18,731	870 Added 8.39%	11,244 $45,000
Q4 2019 Feb 14, 2020	SELL	$13.94 - $24.12 $185,541 - $321,037	-13,310 Reduced 56.2%	10,374 $222,000

Q3 2019 Nov 14, 2019	SELL	$13.89 - $23.16 $206,363 - $344,088	-14,857 Reduced 38.55%	23,684 $359,000
Q2 2019 Aug 14, 2019	BUY	$16.27 - $20.51 $140,182 - $176,714	8,616 Added 28.79%	38,541 $747,000
Q1 2019 May 15, 2019	BUY	$12.61 - $22.33 $136,629 - $241,945	10,835 Added 56.76%	29,925 $621,000
Q4 2018 Feb 14, 2019	BUY	$12.41 - $22.98 $236,906 - $438,688	19,090 New	19,090 $260,000

184

87.9M

528K

219K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $282M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.